DAEWOONG PHARMA Logo

DAEWOONG PHARMA

A global R&D partner for drug development, manufacturing, and commercialization services.

069620 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 화성시 향남읍 제약공단4길 35-14, 화성시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Daewoong Pharmaceutical is a research and development-oriented pharmaceutical company established in 1945. The company manufactures and sells a range of healthcare products, including prescription drugs, over-the-counter medicines, and active pharmaceutical ingredients (APIs). A core component of its strategy is an "Open Collaboration" model, through which it partners with academic and industry collaborators globally to develop innovative, first-in-class drugs. Daewoong provides comprehensive support to its partners, including R&D investment, access to GMP-certified manufacturing facilities for biologics like stem cells, clinical trial support, and formulation services, from initial idea validation through to commercialization.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for DAEWOONG PHARMA and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-15 00:00
Regulatory News Service
투자판단관련주요경영사항
Korean 14.2 KB
2025-09-05 00:00
Regulatory News Service
투자판단관련주요경영사항
Korean 8.3 KB
2025-08-18 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.5 KB
2025-08-18 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 37.1 KB
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 4.1 MB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 6.5 MB

Automate Your Workflow. Get a real-time feed of all DAEWOONG PHARMA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for DAEWOONG PHARMA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
KOA SHOJI HOLDINGS CO.,LTD. Logo
Imports APIs and manufactures generic drugs for Japan's pharmaceutical industry.
Japan 9273
KOBAYASHI PHARMACEUTICAL  CO.,LTD. Logo
Manufactures OTC pharma, personal care, and household goods for niche consumer markets.
Japan 4967
Kohjin Bio Co., Ltd. Logo
A CDMO providing culture media & bioservices for cell therapy, research, and diagnostics.
Japan 177A
KOLON LIFE SCIENCE Inc. Logo
Develops gene therapies and manufactures APIs, providing global CDMO/CMO services.
South Korea 102940
Kolon TissueGene, Inc. Logo
Developing cell and gene therapies for orthopedic and degenerative disorders.
United States of America 950160
Develops animal health products and novel drugs for human cancer and autoimmune diseases.
South Korea 041960
KOREA ARLICO PHARM CO.,LTD. Logo
Manufactures generic drugs and provides CDMO services to a global market.
South Korea 260660
Develops and manufactures prescription (ETC) and over-the-counter (OTC) medicines for public health.
South Korea 014570
K Pharma,Inc. Logo
Develops iPS cell-based drugs and regenerative medicine for central nervous system disorders.
Japan 4896
Kringle Pharma,Inc. Logo
Develops regenerative HGF medicines for rare and intractable neurological diseases.
Japan 4884

Talk to a Data Expert

Have a question? We'll get back to you promptly.